Health
Targeted treatments for EGFR-positive lung cancer can improve outcomes – Medical News Today
Targeted therapies are available for people with EGFR mutations, and they tend to be more effective. Learn more about the treatment…
EGFR mutations account for about 1015% of lung cancer cases in the United States. Biomarker testing allows oncologists to choose targeted treatments for these types of lung cancer.
Non-small cell lung cancer (NSCLC) accounts for about 85%
of lung cancer…
Continue Reading
-
Noosa News11 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Noosa News18 hours agoCibaria Noosa, Noosa Heads Review
-
Business16 hours agoCounter drone company surges past $1 billion valuation with new contract win